Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JBS
JBS logo

JBS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Jbs NV (JBS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
17.960
1 Day change
3.58%
52 Week Range
18.000
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

JBS is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows strong growth potential with a 23% upside based on analyst ratings, positive financial performance, and favorable options sentiment. While there are no significant trading signals or congress trading data, the company's expansion plans and strong earnings growth make it a solid investment opportunity.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 74.727, and moving averages are converging, suggesting no immediate overbought or oversold conditions. The stock is trading near its resistance level of 16.676, which could act as a breakout point if surpassed.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment, with significantly higher call activity compared to puts. Implied volatility is low, suggesting stable market expectations.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
11

Positive Catalysts

  • UBS initiated coverage with a Buy rating and a $19.50 price target, implying a 23% upside.

  • Strong Q4 2025 financial performance with a 15.47% YoY revenue increase.

  • Expansion plans with $1B annual capex expected to drive growth.

  • Positive sentiment in options data, with low put-call ratios.

Neutral/Negative Catalysts

  • Gross margin dropped by 16.51% YoY in Q4 2025, indicating cost pressures.

  • No significant hedge fund or insider trading trends to support momentum.

Financial Performance

JBS reported strong financials for Q4 2025, with revenue increasing by 15.47% YoY to $23.06 billion. Net income rose slightly by 0.55% YoY to $415.14 million, and EPS remained stable at 0.37. However, gross margin declined by 16.51% YoY, reflecting cost pressures.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

UBS initiated coverage with a Buy rating and a $19.50 price target, citing a 23% upside. Analysts are optimistic about the company's U.S. listing and expansion plans, which are expected to drive growth over the next two years.

Wall Street analysts forecast JBS stock price to rise
8 Analyst Rating
Wall Street analysts forecast JBS stock price to rise
8 Buy
0 Hold
0 Sell
Strong Buy
Current: 17.960
sliders
Low
17
Averages
19.07
High
22
Current: 17.960
sliders
Low
17
Averages
19.07
High
22
Barclays
Overweight
maintain
$22 -> $23
AI Analysis
2026-03-27
New
Reason
Barclays
Price Target
$22 -> $23
AI Analysis
2026-03-27
New
maintain
Overweight
Reason
Barclays raised the firm's price target on JBS to $23 from $22 and keeps an Overweight rating on the shares. The firm views the company's Q4 report as solid. JBS continues to post "healthy" cash flow despite weakness in U.S. beef with its geographically diversified portfolio, the analyst tells investors in a research note.
UBS
Matheus Enfeldt
initiated
$19.50
2026-02-06
Reason
UBS
Matheus Enfeldt
Price Target
$19.50
2026-02-06
initiated
Reason
UBS analyst Matheus Enfeldt last night initiated coverage of JBS with a Buy rating and $19.50 price target, which implies 23% upside. The firm expects the stock to re-rate following the U.S. listing and joins indices in the country, a process which it says typically lasts for two years. In addition, returns from JBS's $1B annual expansion capex remain unpriced by the market, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JBS
Unlock Now

People Also Watch